Graphical Abstract Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 inhibitors (SGLT2) are key treatments for type 2 diabetes that improve cardiovascular and renal outcomes [1,2,3]
Lindeman, Low blood glutathione levels in healthy aging adults , Journal of Laboratory and Clinical Medicine, 120 (5), 1992, s
Benefits are observed across the spectrum of cardiometabolic disease, including individuals with type 2 diabetes, CKD, and ASCVD [6, 14, 41, 42]
The discrepancies may be attributed to the limitations of BMI as a lone evaluator of metabolic disorders
TB-500, with its systemic action, may be particularly useful for cervical herniations since it does not require injection near the sensitive cervical structures